Novakand Pharma AB (publ) (STO:NOVKAN)
Sweden
· Delayed Price · Currency is SEK 0.110
+0.007 (6.59%)
Mar 10, 2026, 11:20 AM CET
Novakand Pharma AB Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
5
Market Cap
12.51M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Fluicell AB | 15.22M |
| NanoEcho AB | 487.00K |
| Aptahem AB | 2.59M |
| Stayble Therapeutics AB | 47.00K |
| ExpreS2ion Biotech Holding AB | 10.85M |
| Nanologica AB | 21.13M |
| 2cureX AB | 1.98M |
| AcouSort AB | 10.43M |